⚠ AI-Generated

The summary below was generated by an AI language model and may contain errors or omissions. All other content on this page is deterministically extracted from the original SEC EDGAR filing.

Bristol-Myers Squibb substantively modified eight risk factors between 2024 and 2025, including heightened disclosures on legal matters, ESG-related liabilities, pharmaceutical pricing pressures, and regulatory compliance obligations. The company maintained 15 risk factors without change while adding no new risks and removing none, indicating a strategic refinement of existing risk narratives rather than a shift in the company's overall risk profile. The modifications appear concentrated on regulatory, legal, and market pressures affecting revenue and operational costs.

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

🟡 Modified Legal matters could negatively affect our business. 🔒

🟡 Modified Expectations relating to environmental, social and governance considerations and related reporting obligations expose the Company to potential liabilities, increased costs, reputational harm, and other adverse effects on the Company’s business. 🔒

🟡 Modified Increased pricing pressure and other restrictions in the U.S. and abroad continue to negatively affect our revenues and profit margins. 🔒

🟡 Modified We are subject to a variety of U.S. and international laws and regulations. 🔒

🟡 Modified We are dependent on information technology systems, including artificial intelligence programs, and face risk of cybersecurity incidents that could disrupt our business and result in theft of proprietary, confidential and personal information. 🔒

🟡 Modified Product labeling changes for our marketed products could result in a negative impact on revenues and profit margins. 🔒

🟡 Modified Use of social media platforms can present risks and challenges. 🔒

🟡 Modified Changes to tax regulations could negatively impact our earnings. 🔒

8 changes in this historical filing

Historical year-over-year comparisons (2025 vs 2024 and earlier) are available on the Pro plan.

Get full access — from $29/month Already a Pro subscriber? View full diff →